Weekly Results: S&P 500 1,004.09 -.63% , DJIA 9,321.40 -.52% , NASDAQ 1,985.52 -.74% , Russell 2000 563.90 -1.49% and MSCI Emerging Markets 36.03 -1.11%
Early hints of pullbacks:
Global markets begin to cool off as summer days begin to wind down. Chinese markets hit an early peak on August 3rd and few days later the US Dollar stopped its downside bleeding. Yet again, we're reminder of a slowing appetite for risky assets. At the same time, observers await for further downside confirmation. Somehow, sentiment feels upbeat in the search of a promising finish to 2009. This is showcased by increasing number of pundits and economist declaring an “end” to the recession.
In weeks ahead, skepticism is poised to increase along with perceived volatility. At this stage, cheerleading stock market returns may dangerously reflect hope than substance. For example, a simple S&P 500 Price-Earnings Ratio currently stands at 18.35. At the start of the recovery in March the P/E ratio equaled 10. (Bespoke 8/14) Therefore, the index is a bit pricey for investors seeking bargains at attractive entry points. Beyond price performance, markets seem mysterious for one to figure out key drivers of this recent rally. At this junction crafting a buy pitch for prudent investors is a tough sell.
That said, impact of government spending is too powerful and biased towards the upside. Therefore, it remains a key part of the bullish equation.
Narrow focus on innovation
Crude is moderately retracing, markets are pausing, and plenty of speculative calls for currency reversals. In addition, message from the Federal Reserve is ambiguous similar to economic data results. However, these times require ambitious investors to focus on innovative ideas. Basically, innovation is desperately needed given adjustment and consolidation to traditional industries such as Auto’s and Financials. Therefore, finding niche growth areas is challenging but can be rewarding especially in Technology and Biotechnology. For example, two public offerings last week (CPIX Cumberland Pharmaceuticals and EM Emdeon) demonstrate developing strength in Healthcare.
Actionable Trends:
Case for soft commodities
At this point,Hard Commodities are becoming extended. Gold, Crude and Steel are likely to see shrinking demand and increasing inventories. Investor expectations in the long Crude and China trade might disappoint given high expectations. Importantly, supply shortage of softer commodities such as Sugar and Grains can continue to create higher demand. For example, commonly followed Sugar #11 Index is trading at all-time highs. Therefore, money managers might consider reshuffling and reaction to shortage in food supplies.
Profit taking or Short:
PTR (PetroChina) : Twice this summer,stock failed to get above $120. Investors link risky assets with stocks exposed to China and Crude. Poised to decline closer to $100 range where more buyers will potentially take a closer look.
Appealing buys on pullbacks:
ADM (Archer Daniels Midland): Company stands to benefit from increasing agriculture demand including wheat, corn, protein and other food ingredients. Add on weakness given a promising longer-term outlook and healthy balance sheet.
· EMS (Emergent BioSolutions): For aggressive investors seeking exposure in Healthcare. The company demonstrated strong sales in vaccine related products and recent FDA approval. Interestingly, fundamentals are attractive given the company's dominance in the vaccine space. Additionally, attractive chart pattern provides positive flow for this small cap stock.
Ideas from previous post:
Profit taking / Short: GG (Gold Corp), SCHN (Schnitzer Steel) and X (US Steel)
Longs: CWT (California Water) MATK (Martek Biosciences) and RFMD (RF Micro)CREE (Cree Inc), LLTC (Linear Technology) and ONXX (Onxx Pharmaceutical).
Article Quotes:
“Copper inventories monitored by the London Metal Exchange surged 14 percent since July 14. U.S. industrial output rose in July from June, the first month-to-month gain since October, Federal Reserve data showed today in Washington. “ (Bloomberg, August 14, 2009)
“The financing gap turned sharply negative at the end of last year. This negative financing gap indicates that the business sector as a whole is generating enough cash to purchase capital expenditures without borrowing. This supports the claims of banks that demand for business loans has declined. But that isn't necessarily good news for the economy.” (Clusterstock, August 11, 2009).
Levels:
S&P 500 [1004.09] Stabilizing and poised to hold around 1000. Early indication of a pause following a brief declines from August 7th highs.
Crude [$67.51] Failed to reach above $74 (200 day moving average). Establishing a wide range between $70-60. In the short-term, downside momentum is building.
Gold [$953.50] Index floating between a multi-month trading range between $850-950.
DXY– US Dollar Index [78.88] Slightly holding above annual lows. The dollar index remains deeply oversold but noteworthy intra-day bottom on August 5. This sets the stage for a long awaited turnaround.
US 10 Year Treasury Yields [3.56%] Since June, Treasury yields failed to climb above 3.80%. This suggests that additional catalysts are required for a convincing rise in yields.
Dear Readers:
The positions and strategies discussed on MarketTakers are offered for entertainment purposes only and are in no way intended to serve as personal investing advice. Readers should not make any investment decision without first conducting their own thorough due diligence. Readers should assume the editor holds a position in any securities discussed, recommended or panned. While the information provided is obtained from sources believed to be reliable, its accuracy or completeness cannot be guaranteed, nor can this publication be, in any Publish Post, considered liable for the future investment performance of any securities or strategies discussed.